RU2563123C1
|
|
Method of treating cerebral oedema
|
RU2571282C1
|
|
Method for stroke treatment
|
RU2550262C1
|
|
Monoclonal antibody against human interleukin-6 and hybridoma producing this monoclonal antibody
|
RU2538724C1
|
|
Method of treating epilepsy
|
RU2554820C2
|
|
Method for anti-immunoglobulin e antibody neutralisation activity test
|
RU2564120C2
|
|
STRAIN OF Escherichia coli BACTERIA - PRODUCENT OF HEAT SHOCK PROTEIN 70 AND METHOD FOR OBTAINING PREPARATION OF HUMAN HEAT SHOCK PROTEIN
|
RU2524133C2
|
|
Escherichia coli BACTERIA STRAIN - PRODUCER OF RECOMBINANT FLAGELLIN
|
RU2562169C2
|
|
Culture cell strain cho-il7/13 producing human interleukin-7
|
RU2524138C2
|
|
Agent inhibiting escherichia coli o75 №5557 bacterial activity (versions)
|
RU2499043C1
|
|
Promoting agent of proliferation of regulatory t-lymphocyte, and their promotion method
|
RU2487547C1
|
|
"vitaflor-p" dry probiotically active preparation
|
RU2465010C1
|
|
Contrast agent for magnetic resonance tomography
|
RU2425576C1
|
|
Dry probiotically active biopreparation and method for production of fermented milk drink based on it
|
RU2422133C1
|
|
Hydrophylic gel, method of its obtaining (versions), wound covering and based on it bandage means
|
RU2410082C1
|
|
Zinc-containing aerosol composition
|
RU2412946C1
|
|
METHOD OF OBTAINING ANTIBODIES TO PROTEIN p17HIV
|
RU2437649C2
|
|
Method of obtaining dry liposomal preparations (versions)
|
RU2491956C2
|
|
Method of treating vaginal infections
|
RU2406572C2
|
|
Aerosolisation installation
|